Is there a role for oral human immunoglobulin in the treatment for norovirus enteritis in immunocompromised patients?

Influence of Novel Norovirus GII.4 Variants on Gastroenteritis Outbreak Dynamics in Alberta and the Northern Territories, Canada between 2000 and 2008

(2010) Xiaoli L. Pang et al.   PLoS One

Allogeneic Hematopoietic Stem Cell Transplantation and Norovirus Gastroenteritis: A Previously Unrecognized Cause of Morbidity

(2009) C. Roddie et al.   CLINICAL INFECTIOUS DISEASES

Seroepidemiological study of norovirus infection in Aichi Prefecture, Japan

(2009) Shinichi Kobayashi et al.   MICROBIOLOGY AND IMMUNOLOGY

Epidemics of Gastroenteritis during 2006 Were Associated with the Spread of Norovirus GII.4 Variants 2006a and 2006b

(2008) E. T.- V. Tu et al.   CLINICAL INFECTIOUS DISEASES

Sequential evolution of genotype GII.4 norovirus variants causing gastroenteritis outbreaks from 2001 to 2006 in Eastern Spain

(2008) Javier Buesa et al.   JOURNAL OF MEDICAL VIROLOGY

Quantitative detection of norovirus excretion in pediatric patients with cancer and prolonged gastroenteritis and shedding of norovirus

(2008) A. Ludwig et al.   JOURNAL OF MEDICAL VIROLOGY

Two cases of Norwalk virus enteritis following small bowel transplantation treated with oral human serum immunoglobulin

(2008) Diana F. Florescu et al.   PEDIATRIC TRANSPLANTATION